Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

RITE AID CORPORATION

(RAD)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/14/2021 10/15/2021 10/18/2021 10/19/2021 10/20/2021 Date
14.4(c) 13.85(c) 13.65(c) 13.63(c) 14.22(c) Last
1 930 385 1 327 618 1 574 975 1 309 650 3 703 568 Volume
+2.27% -3.82% -1.44% -0.15% +4.33% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 25 023 M - -
Net income 2022 -184 M - -
Net Debt 2022 2 868 M - -
P/E ratio 2022 -4,18x
Yield 2022 -
Sales 2023 25 504 M - -
Net income 2023 -72,6 M - -
Net Debt 2023 2 833 M - -
P/E ratio 2023 -10,6x
Yield 2023 -
Capitalization 771 M 771 M -
EV / Sales 2022 0,15x
EV / Sales 2023 0,14x
Nbr of Employees 50 000
Free-Float 97,2%
More Financials
Company
Rite Aid Corporation is a healthcare company that operates retail drugstore chain. The Company is principally engaged in providing its service to customers and communities through various programs. Its business segments include Retail Pharmacy segment and Pharmacy Services segment. Retail Pharmacy segment sells brand and generic prescription drugs and various other pharmacy services, as well as front-end products,... 
Sector
Drug Retailers
Calendar
12/23Earnings Release
More about the company
Ratings of Rite Aid Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about RITE AID CORPORATION
10/20RITE AID : Deutsche Bank Adjusts Rite Aid PT to $15 From $13, Maintains Hold Rating
MT
10/05RITE AID : Management's Discussion and Analysis of Financial Condition and Results of Cont..
AQ
10/02RITE AID : Pharmacies face 1st trial over role in opioid crisis
AQ
10/01Pharmacy chains face first trial in U.S. opioid litigation, judge urges settlement
RE
09/24RITE AID : Statement on CDC Recommendation Regarding COVID-19 Vaccine “Boosters&rdqu..
BU
09/24RITE AID : Expands Partnership With Uber to Deliver Products Across US Via Uber Eats
MT
09/24RITE AID : Partners With Uber Eats to Expand On-Demand Delivery Nationwide
BU
09/24Rite Aid Partners With Uber Eats to Expand On-Demand Delivery Nationwide
CI
09/24Rite Aid Expands Partnership With Uber
DJ
09/23Salesforce.com, Darden rise; Steelcase, Rite Aid fall
AQ
09/23RITE AID : Swings to Fiscal Q2 Adjusted Loss; Revenue Advances
MT
09/23Equity Futures Signal Stronger Session After Fed Meeting; Europe, Asia Move Higher
MT
09/23RITE AID : Second Quarter Net Loss from Continuing Operations of $100.3 Million or $1.86 P..
PU
09/23RITE AID : Fiscal Q2 Earnings Snapshot
AQ
09/23RITE AID CORP : Results of Operations and Financial Condition, Financial Statements and Ex..
AQ
More news
News in other languages on RITE AID CORPORATION
09/24Rite Aid étend son partenariat avec Uber pour livrer des produits à travers les États-U..
09/23Rite Aid subit une perte ajustée au deuxième trimestre fiscal, mais ses revenus augment..
09/23Les contrats à terme sur actions annoncent une session plus forte après la réunion de l..
09/23Wall Street s'avance avant la cloche ; Futures verts, Europe en hausse, Asie en hausse
09/23Rite Aid Corporation fournit des prévisions de bénéfices pour l'année fiscale 2022
More news
Analyst Recommendations on RITE AID CORPORATION
More recommendations
Chart RITE AID CORPORATION
Duration : Period :
Rite Aid Corporation Technical Analysis Chart | RAD | US7677548726 | MarketScreener
Technical analysis trends RITE AID CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 3
Last Close Price 14,22 $
Average target price 12,67 $
Spread / Average Target -10,9%
EPS Revisions
Managers and Directors
Heyward R. Donigan President, Chief Executive Officer & Director
Matthew C. Schroeder Chief Financial Officer & Executive Vice President
Bruce G. Bodaken Chairman
Justin Mennen Chief Information Officer & Executive VP
Lance Neill Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
RITE AID CORPORATION-10.17%771
RAIA DROGASIL S.A.-13.46%6 448
AIN HOLDINGS INC.8.16%2 125
PETMED EXPRESS, INC.-15.72%545
QOL HOLDINGS CO., LTD.47.47%532
HLS THERAPEUTICS INC.7.89%510